You are here: Industry Insights > license

News List

Recro, Teva Extend License and Supply Agreement contractpharma
April 18, 2019
Recro Gainesville, the contract development and manufacturing organization (CDMO) division of Recro Pharma, has amended its existing license and supply agreement with ...
Numab & Intarcia Enter License Agreement contractpharma
March 07, 2019
Intarcia Therapeutics Inc. has executed its option to in-license ND016, being developed for the treatment of autoimmune disorders
WuXi STA, Ark Biosciences Sign CMC Devt. & Mfg. Deal contractpharma
March 07, 2019
The CDMO will provide Ark with integrated services for in process R&D and manufacturing
Amgen, Molecular Partners Enter Immunotherapy Alliance contractpharma
December 21, 2018
Amgen and Molecular Partners AG, a biotech company developing DARPin therapeutics, have entered a collaboration and license agreement for the clinical development and commercialization of MP0310...
Chi-Med and Lilly Amend 2013 Agreement contractpharma
December 21, 2018
Hutchison China MediTech has announced a change (“2018 Amendment”) to the 2013 License and Collaboration Agreement on fruquintinib with Lilly Shanghai, an affiliate of Eli Lilly and Company.
Orchard & SIRION Enter License Agreement contractpharma
December 17, 2018
Orchard Therapeutics and SIRION Biotech GmbHhave entered into a license agreement, through which Orchard has licensed SIRION’s LentiBOOST™ technology to enhance manufacturing efficiency for certain of Orchard’s ex vivo
Entera & Amgen Sign Research Agreement contractpharma
December 12, 2018
Entera Bio has entered into a research collaboration and license agreement with Amgen in inflammatory disease and other serious illnesses.
TRACON & I-Mab Partner for Immuno-Oncology contractpharma
November 30, 2018
TRACON Pharmaceuticals and I-Mab Biopharmajointly announced the establishment of a series of strategic collaborative partnerships for developing multiple immuno-oncology programs, including I-Mab’s proprietary CD73 antibody TJD5
Immunocore, Genentech Expand Anti-Cancer Alliance contractpharma
November 28, 2018
Immunocore Ltd., a T Cell Receptor (TCR) biotechnology company, has entered into a new partnership with Genentech, a member of the Roche Group, to expand an existing discovery
CBT, Bossan Enter Clinical Collaboration contractpharma
November 27, 2018
CBT Pharmaceuticals (CBT) and Zhejiang Bossan Pharmaceutical Co., Ltd (Bossan) have entered into a clinical collaboration and license agreement to develop their respective assets in combination with each other.

Previous page 1 2 Next page